Cite
APA Citation
Goss, C. H., Jain, R., Seibold, W., Picard, A., Hsu, M., Gupta, A., & Fajac, I. (2020). an innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CFTM 1. ERJ open research, 6(4), . http://access.bl.uk/ark:/81055/vdc_100172001773.0x0000fc